NCT00148213View on ClinicalTrials.gov

Clinical Evaluation of a New Highly Sensitive Thyroglobulin Assay in Differentiated Thyroid Carcinoma

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 2003

Study Completion Date

June 30, 2005

Conditions
Thyroid Neoplasms
Trial Locations (1)

48129

Department of Nuclear Medicine, Münster University Hospital, Münster

All Listed Sponsors
collaborator

Nichols Institute Diagnostika GmbH, Bad Vilbel, Germany

UNKNOWN

lead

University Hospital Muenster

OTHER

NCT00148213 - Clinical Evaluation of a New Highly Sensitive Thyroglobulin Assay in Differentiated Thyroid Carcinoma | Biotech Hunter | Biotech Hunter